# Cerebrolysin with thrombectomy for stroke: 90-day recovery

Source: https://pepvault.app/research/cerebrolysin-staszewski-2025

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Cerebrolysin](https://pepvault.app/research#cerebrolysin)

Clinical trial · people

# Cerebrolysin after thrombectomy: 68% vs 44% independent at 90 days

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This study adds an early, non-randomized signal of better 90-day recovery with Cerebrolysin after thrombectomy in a selected stroke group, which still needs confirmation in randomized trials.

- **Kind:** Clinical trial
- **Studied in:** People
- **Published:** 2025
- **Journal:** Transl Stroke Res

## What they tested

The team tested whether adding Cerebrolysin to mechanical thrombectomy (removing a brain clot with a device) improves recovery and safety after a major ischemic stroke.

## How the study was done

An open-label, single-arm study at one center of 50 consecutive adults with moderate-to-severe ischemic stroke from a large artery blockage, all treated with thrombectomy within 6 h of onset, with outcomes scored by assessors who were blinded. Patients got Cerebrolysin 30 ml by IV through day 21, then a second cycle between days 69 and 90, and were compared with 50 past patients matched by propensity scores (a statistical matching method).

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At 90 days, 68% of the Cerebrolysin group were functionally independent (mRS 0-2, a disability score) versus 44% of controls (OR 2.7, 95% CI 1.2-6.1). Secondary brain bleeding was less common, at 14% versus 40% (RR 0.37), and the median NIHSS stroke severity score on day 7 was 3 versus 6. Barthel Index scores, a measure of daily-living ability, were higher at 30 days (median 77 vs 63) and at 3 months (86 vs 75), mostly from mobility and transfer items. Deaths were similar between groups, at 2% vs 6% at 30 days and 8% vs 12% at 90 days.

## What it doesn’t show

This was not a randomized trial: everyone knew they were getting Cerebrolysin, the comparison group came from earlier patients, and it ran at one center for 3 months. It only included selected patients with good collateral blood flow and successful clot removal, and the authors call for randomized trials to confirm the results.

## The paper

Staszewski et al. Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study. Transl Stroke Res. 2025.

- [PubMed (PMID 40325343)](https://pubmed.ncbi.nlm.nih.gov/40325343/)
- [The paper (DOI 10.1007/s12975-025-01355-z)](https://doi.org/10.1007/s12975-025-01355-z)
- [ClinicalTrials.gov (NCT04904341)](https://clinicaltrials.gov/study/NCT04904341)

## The compound

- [Cerebrolysin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

## With this study

### Cerebrolysin

- [Cerebrolysin: the full reference](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

### Studies

- [Cerebrolysin: small cognitive gain in vascular dementia, weak evidence](https://pepvault.app/research/cerebrolysin-cui-2019)
- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018)
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015)
- [All 6 studies](https://pepvault.app/research#cerebrolysin)

### Compared with

- [Semax vs Cerebrolysin](https://pepvault.app/peptides/compare/semax-vs-cerebrolysin)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Cycle](https://pepvault.app/glossary/cycle)
- [Open-label](https://pepvault.app/glossary/open-label)

## More studies on Cerebrolysin

- [Cerebrolysin: small cognitive gain in vascular dementia, weak evidence](https://pepvault.app/research/cerebrolysin-cui-2019) Meta-analysis · people · 2019
- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018) Meta-analysis · people · 2018
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015) Meta-analysis · people · 2015
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016) Randomized trial · people · 2016
- [Cerebrolysin: no overall benefit in acute ischemic stroke at 90 days](https://pepvault.app/research/cerebrolysin-heiss-2012) Randomized trial · people · 2012
- [Every study on Cerebrolysin](https://pepvault.app/research#cerebrolysin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Cerebrolysin

- [Cerebrolysin: the full reference](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

### Studies

- [Cerebrolysin: small cognitive gain in vascular dementia, weak evidence](https://pepvault.app/research/cerebrolysin-cui-2019)
- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018)
- [Cerebrolysin beat placebo on global change in Alzheimer's at 6 months](https://pepvault.app/research/cerebrolysin-gauthier-2015)
- [All 6 studies](https://pepvault.app/research#cerebrolysin)

### Compared with

- [Semax vs Cerebrolysin](https://pepvault.app/peptides/compare/semax-vs-cerebrolysin)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Cycle](https://pepvault.app/glossary/cycle)
- [Open-label](https://pepvault.app/glossary/open-label)

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Cerebrolysin](https://pepvault.app/research#cerebrolysin)

## The library

- [Cerebrolysin](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
